HIGHLIGHTS
- who: Sezaneh Haghpanah from the In this cross-sectional study, from January , to January, patients with TDT over the age of , participatedAll patients were registered at the Thalassemia Comprehensive Center, affiliated with Shiraz University of Medical Sciences in Shiraz, Southern Iran. Diagnosis of TDT patients was based on clinical history and hemoglobin electrophoresis. Inclusion criteria were TDT patients with regular blood transfusion every, weeks to sustain hemoglobin levels between, g/dl and receiving one type of ICT regimen within the last two years. Iron chelation regimens consisted of deferoxamine, deferasirox, or deferiprone with appropriate dosage either as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.